Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Shen

Showing results (921-930 of 1,551) with videos related to

Pageof 156
Sort By:
Frontiers in Oncology|January 23, 2023
CT-based delta radiomics in predicting the prognosis of stage IV gastric cancer to immune checkpoint inhibitorsJiazheng Li, Zifan Chen, Yang Chen, et al.
International Journal of Cancer|January 23, 2013
Folic acid supplementation and cancer risk: a meta-analysis of randomized controlled trialsXianhui Qin, Yimin Cui, Lin Shen, et al.
Molecular Pharmaceutics|September 26, 2018
Noninvasive Detection of HER2 Expression in Gastric Cancer by <sup>64</sup>Cu-NOTA-Trastuzumab in PDX Mouse Model and in PatientsXiaoyi Guo, Hua Zhu, Nina Zhou, et al.
American Journal of Cancer Research|February 18, 2020
Conditionally reprogrammed colorectal cancer cells combined with mouse avatars identify synergy between EGFR and MEK or CDK4/6 inhibitorsYanni Wang, Haiyan Liao, Tongsen Zheng, et al.
BMC Cancer|December 7, 2023
Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challengesJing Gao, Jianqiang Lan, Haiyan Liao, et al.
Oncotarget|February 6, 2016
Intratumoral KIT mutational heterogeneity and recurrent KIT/ PDGFRA mutations in KIT/PDGFRA wild-type gastrointestinal stromal tumorsJing Gao, Jian Li, Yanyan Li, et al.
Oncotarget|May 19, 2016
Programmed death-ligand-1 expression in advanced gastric cancer detected with RNA in situ hybridization and its clinical significanceJiajia Yuan, Jie Zhang, Yan Zhu, et al.
BMC Cancer|November 13, 2015
Dual PI3K/mTOR inhibitor BEZ235 exerts extensive antitumor activity in HER2-positive gastric cancerYan Zhu, Tiantian Tian, Jianling Zou, et al.
Cancer Letters|January 26, 2018
Targeting c-Myc: JQ1 as a promising option for c-Myc-amplified esophageal squamous cell carcinomaJingyuan Wang, Zhentao Liu, Ziqi Wang, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 15, 2025
Noninvasive in vivo tracking of SPIONs-labeled CLDN18.2-targeted CAR-T cells in gastric cancer via magnetic particle imagingMeng He, Lijie Ge, Hui Hui, et al.
Pageof 156

Showing results (921-930 of 1,551) with videos related to

Sort By:
Pageof 156
Frontiers in Oncology|January 23, 2023
CT-based delta radiomics in predicting the prognosis of stage IV gastric cancer to immune checkpoint inhibitorsJiazheng Li, Zifan Chen, Yang Chen, et al.
International Journal of Cancer|January 23, 2013
Folic acid supplementation and cancer risk: a meta-analysis of randomized controlled trialsXianhui Qin, Yimin Cui, Lin Shen, et al.
Molecular Pharmaceutics|September 26, 2018
Noninvasive Detection of HER2 Expression in Gastric Cancer by <sup>64</sup>Cu-NOTA-Trastuzumab in PDX Mouse Model and in PatientsXiaoyi Guo, Hua Zhu, Nina Zhou, et al.
American Journal of Cancer Research|February 18, 2020
Conditionally reprogrammed colorectal cancer cells combined with mouse avatars identify synergy between EGFR and MEK or CDK4/6 inhibitorsYanni Wang, Haiyan Liao, Tongsen Zheng, et al.
BMC Cancer|December 7, 2023
Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challengesJing Gao, Jianqiang Lan, Haiyan Liao, et al.
Oncotarget|February 6, 2016
Intratumoral KIT mutational heterogeneity and recurrent KIT/ PDGFRA mutations in KIT/PDGFRA wild-type gastrointestinal stromal tumorsJing Gao, Jian Li, Yanyan Li, et al.
Oncotarget|May 19, 2016
Programmed death-ligand-1 expression in advanced gastric cancer detected with RNA in situ hybridization and its clinical significanceJiajia Yuan, Jie Zhang, Yan Zhu, et al.
BMC Cancer|November 13, 2015
Dual PI3K/mTOR inhibitor BEZ235 exerts extensive antitumor activity in HER2-positive gastric cancerYan Zhu, Tiantian Tian, Jianling Zou, et al.
Cancer Letters|January 26, 2018
Targeting c-Myc: JQ1 as a promising option for c-Myc-amplified esophageal squamous cell carcinomaJingyuan Wang, Zhentao Liu, Ziqi Wang, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 15, 2025
Noninvasive in vivo tracking of SPIONs-labeled CLDN18.2-targeted CAR-T cells in gastric cancer via magnetic particle imagingMeng He, Lijie Ge, Hui Hui, et al.
Pageof 156